Stryker Intangible Assets from 2010 to 2026

SYK Stock  USD 366.05  0.20  0.05%   
Stryker Intangible Assets yearly trend continues to be quite stable with very little volatility. Intangible Assets may rise above about 26.2 B this year. Intangible Assets is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. View All Fundamentals
 
Intangible Assets  
First Reported
1985-12-31
Previous Quarter
5.8 B
Current Value
25 B
Quarterly Volatility
2.7 B
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Stryker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stryker's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 B, Interest Expense of 478.2 M or Total Revenue of 26.4 B, as well as many indicators such as Price To Sales Ratio of 3.06, Dividend Yield of 0.0054 or PTB Ratio of 6.39. Stryker financial statements analysis is a perfect complement when working with Stryker Valuation or Volatility modules.
  
Build AI portfolio with Stryker Stock
Check out the analysis of Stryker Correlation against competitors.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
Historical Intangible Assets data for Stryker serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Stryker represents a compelling investment opportunity.

Latest Stryker's Intangible Assets Growth Pattern

Below is the plot of the Intangible Assets of Stryker over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Stryker's Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Stryker's overall financial position and show how it may be relating to other accounts over time.
Intangible Assets10 Years Trend
Slightly volatile
   Intangible Assets   
       Timeline  

Stryker Intangible Assets Regression Statistics

Arithmetic Mean5,853,111,765
Geometric Mean2,530,657,392
Coefficient Of Variation129.71
Mean Deviation4,645,456,055
Median4,163,000,000
Standard Deviation7,591,994,890
Sample Variance57638386.4T
Range26.2B
R-Value0.70
Mean Square Error31161860.7T
R-Squared0.49
Significance0
Slope1,055,780,392
Total Sum of Squares922214182.4T

Stryker Intangible Assets History

202626.2 B
202525 B
20244.4 B
20234.6 B
20224.9 B
20214.8 B
20205.6 B

About Stryker Financial Statements

Stryker investors utilize fundamental indicators, such as Intangible Assets, to predict how Stryker Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Intangible Assets25 B26.2 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:
Check out the analysis of Stryker Correlation against competitors.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Stryker assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
0.559
Dividend Share
3.4
Earnings Share
8.41
Revenue Per Share
65.714
Quarterly Revenue Growth
0.114
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Stryker's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.